These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
733 related articles for article (PubMed ID: 11379842)
1. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284 [TBL] [Abstract][Full Text] [Related]
3. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. Frazier JA; Biederman J; Tohen M; Feldman PD; Jacobs TG; Toma V; Rater MA; Tarazi RA; Kim GS; Garfield SB; Sohma M; Gonzalez-Heydrich J; Risser RC; Nowlin ZM J Child Adolesc Psychopharmacol; 2001; 11(3):239-50. PubMed ID: 11642474 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Tohen M; Jacobs TG; Grundy SL; McElroy SL; Banov MC; Janicak PG; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson GD; Breier A Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547 [TBL] [Abstract][Full Text] [Related]
6. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression. Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118 [TBL] [Abstract][Full Text] [Related]
8. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [TBL] [Abstract][Full Text] [Related]
9. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G; Tohen M; Qiuqing A; Fude Y; Pope E; McElroy H; Ming L; Gaohua W; Xinbao Z; Huichun L; Liang S J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327 [TBL] [Abstract][Full Text] [Related]
10. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Tohen M; Sanger TM; McElroy SL; Tollefson GD; Chengappa KN; Daniel DG; Petty F; Centorrino F; Wang R; Grundy SL; Greaney MG; Jacobs TG; David SR; Toma V Am J Psychiatry; 1999 May; 156(5):702-9. PubMed ID: 10327902 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883 [TBL] [Abstract][Full Text] [Related]
12. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948 [TBL] [Abstract][Full Text] [Related]
13. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. Houston JP; Ahl J; Meyers AL; Kaiser CJ; Tohen M; Baldessarini RJ J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203 [TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478 [TBL] [Abstract][Full Text] [Related]
15. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Tohen M; Ketter TA; Zarate CA; Suppes T; Frye M; Altshuler L; Zajecka J; Schuh LM; Risser RC; Brown E; Baker RW Am J Psychiatry; 2003 Jul; 160(7):1263-71. PubMed ID: 12832240 [TBL] [Abstract][Full Text] [Related]
16. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Berk M; Ichim L; Brook S Int Clin Psychopharmacol; 1999 Nov; 14(6):339-43. PubMed ID: 10565800 [TBL] [Abstract][Full Text] [Related]
19. Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder. Vieta E; Reinares M; Corbella B; Benabarre A; Gilaberte I; Colom F; Martínez-Arán A; Gastó C; Tohen M J Clin Psychopharmacol; 2001 Oct; 21(5):469-73. PubMed ID: 11593070 [TBL] [Abstract][Full Text] [Related]
20. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder. Hirschfeld RM; Eerdekens M; Kalali AH; Canuso CM; Khan AA; Karcher K; Palumbo JM Int Clin Psychopharmacol; 2006 Jan; 21(1):11-20. PubMed ID: 16317312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]